Benefit-Risk Assessment of Treatments for Heparin-Induced Thrombocytopenia

Author: Messmore H.L.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.26, Iss.9, 2003-01, pp. : 625-641

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract